Abstract
Heart transplantation poses significant opportunities for rehabilitation and survival for patients with heart failure refractory to clinical medical therapy. The main late complication and increasingly important as survival increases is cardiac allograft vasculopathy (VAC) with estimated incidence rate of 10% per year reaching 40-50% in recipients who have completed five years of postoper…